Related Experiment Video
Updated: Jul 24, 2025

Lung CT Segmentation to Identify Consolidations and Ground Glass Areas for Quantitative Assesment of SARS-CoV Pneumonia
Published on: December 19, 2020
COVID-19-Related Pleural Diseases
Beenish Iqbal1, Najib M Rahman1,2, Rob J Hallifax1,2
1Respiratory Trials Unit, Oxford Centre for Respiratory Disease, Oxford University Hospital, Oxford Centre for Respiratory Medicine, Churchill Hospital, NHS Trust, Oxford, United Kingdom.
Insights
COVID-19 can cause serious pleural diseases like pneumothorax and effusion. Early recognition and targeted management of these respiratory complications are crucial for better patient outcomes.
Area of Science:
- Pulmonology
- Infectious Diseases
- Critical Care Medicine
Background:
- COVID-19 is associated with various pleural diseases, including pneumothorax, pneumomediastinum, and pleural effusion.
- These complications are increasingly recognized and are not merely incidental or due to barotrauma.
- The pathophysiology of COVID-19-related pleural complications is complex and linked to severe illness.
Purpose of the Study:
- To review the recognition and management of COVID-19-related pleural diseases.
- To highlight the association between pleural complications and disease severity.
- To emphasize the importance of prompt diagnosis and intervention for improved outcomes.
Main Methods:
- Review of clinical evidence and case reports concerning COVID-19 and pleural diseases.
- Analysis of patient characteristics and management strategies for pneumothorax, pneumomediastinum, and pleural effusion in COVID-19 patients.
- Correlation of pleural complications with disease severity and prognosis.
Main Results:
- COVID-19-related pneumothorax and pneumomediastinum often require assisted ventilation and prompt intervention.
- Pleural effusions in COVID-19 patients, while sharing some characteristics, are generally managed more conservatively.
- Patients with COVID-19-associated pleural air leaks or effusions exhibit more severe disease and a worse prognosis.
Conclusions:
- COVID-19-related pleural diseases signify more severe illness and poorer prognosis.
- Prompt recognition and targeted management of these respiratory complications are essential.
- Understanding the complex pathophysiology is key to optimizing patient care.
Abstract:
Coronavirus disease 2019 (COVID-19)-related pleural diseases are now well recognized. Since the beginning of the pandemic, increasing cases of pleural diseases including pneumothorax, pneumomediastinum, and pleural effusion with severe COVID-19 infection have attracted the attention of physicians and are not incidental or due to barotrauma. The complicated course of COVID-19 illness highlights the complex pathophysiological underpinnings of pleural complications. The management of patients with pneumothorax and pneumomediastinum is challenging as the majority require assisted ventilation; physicians therefore appear to have a low threshold to intervene. Conversely, pleural effusion cases, although sharing some similar patient characteristics with pneumothorax and pneumomediastinum, are in general managed more conservatively. The evidence suggests that patients with COVID-19-related pleural diseases, either due to air leak or effusion, have more severe disease with a worse prognosis. This implies that prompt recognition of these complications and targeted management are key to improve outcomes.
More Related Videos
Related Concept Videos
Pleural Disorders: Types and Brief Description
Pleural Effusion II: Symptoms and Management
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
Pleura of the Lungs
Pleural Effusion I: Introduction
There are two main types of pleural effusion: transudative and exudative. They are differentiated using Light's...
Pneumonia II: Pathophysiology
Pneumonia III: Complications and Assessment

